Latest News about GILD
Recent news which mentions GILD
From Benzinga
Why Is HIV Drug Giant Gilead Stock Falling Monday?
January 22, 2024
From Benzinga
EXCLUSIVE: The 'Buy Everything' Market Is Over: Synopsys-Ansys Merger Provides Fertile Ground For This Stock Picker
January 18, 2024
From Benzinga
From Benzinga
From Benzinga
AbbVie's Strategic Move: ImmunoGen Acquisition Triggers Golden Cross, Yet Valuation Caution Remains
January 11, 2024
From Benzinga
Gilead’s Quiet Revolution: Is GILD the Next Big Stock to Soar?
January 10, 2024
From InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
January 10, 2024
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 08, 2024
From Benzinga
Nasdaq 100 Snaps Longest Negative Streak In 14 Months As Tech Stocks Find Relief On Mixed Data
January 05, 2024
From Benzinga
This Analyst Downgrades Bristol-Myers Squibb, Cautions Amid Product Launch And Revenue Concerns
January 03, 2024
From Benzinga
Nasdaq 100 Alert: 7 Undervalued Tech Stocks Ready to Rocket in 2024
January 03, 2024
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
January 02, 2024
From Benzinga
The 500 Top Stocks to Buy for 2024, Ranked by AI
December 29, 2023
From InvestorPlace
$100 Invested In This Stock 20 Years Ago Would Be Worth $1,100 Today
December 25, 2023
From Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
December 22, 2023
From Benzinga
A Look Into Gilead Sciences Inc's Price Over Earnings
December 22, 2023
From Benzinga
3 Biotech Stocks to Buy in the TradeSmith ‘Green Zone’
December 21, 2023
From InvestorPlace
Why Is Immunotherapy-Focused Hookipa Pharma Stock Soaring Today?
December 21, 2023
From Benzinga
Why Is Hookipa Pharma (HOOK) Stock Up 81% Today?
December 21, 2023
From InvestorPlace
RedHill's Investigational COVID-19 Drugs Combined With Gilead's Show Effect Against Ebola
December 20, 2023
From Benzinga
From Benzinga
Why Is Compugen (CGEN) Stock Up 189% Today?
December 19, 2023
From InvestorPlace
Patients Regain Weight After They Quit Using Ozempic Rival Zepbound. Here's Why That Makes Eli Lilly Stock an Even Better Buy.
December 16, 2023
From Motley Fool
Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development
December 15, 2023
From InvestorPlace
A Bull Market Is Coming: 1 Stock That Could Rocket 219% Higher in 2024, According to Wall Street
December 12, 2023
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
December 11, 2023
From Benzinga
Gilead Sciences Battles Rising Threat of Drug Counterfeiting, Initiates Legal Actions
December 11, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.